| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004131 | American Journal of Ophthalmology | 2010 | 22 Pages |
Abstract
The MUST trial will compare fluocinolone acetonide implant versus systemic therapy for management of intermediate uveitis, posterior uveitis, and panuveitis. Patients with intermediate uveitis, posterior uveitis, or panuveitis enrolled in the trial had a high burden of reduced visual acuity, cataract, macular edema, and epiretinal membrane; overall quality of life was lower than expected based on visual acuity.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
The Multicenter Uveitis Steroid Treatment Trial Research Group The Multicenter Uveitis Steroid Treatment Trial Research Group,